Latest News about Health Care
Recent news which mentions Health Care
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
October 08, 2024
From Benzinga
Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
October 08, 2024
From Benzinga
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
October 08, 2024
From Benzinga
From Benzinga
Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates
October 08, 2024
From Benzinga
Merck Touts Phase 3 Success For $20B Cancer Drug Keytruda In Untreated Head And Neck Cancer Patients
October 08, 2024
Tickers
MRK
From Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
From Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
October 08, 2024
From Benzinga
From Benzinga
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate
October 08, 2024
From Benzinga
Cannabinoids Show Promising Anti-Cancer Potential Yet Mechanisms Remain Unclear, New Study
October 07, 2024
From Benzinga
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
October 07, 2024
From Benzinga
Ketamine Clinics Los Angeles Partners With FireflyVR For Virtual Reality-Enhanced Patient Care
October 07, 2024
Tickers
NEWS
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.